Respiratory Disease Vaccine Market by Vaccine Type (Conjugate Vaccine, Inactivated Vaccine, Live Attenuated Vaccine), Age Group (Adult, Geriatric, Pediatric), Distribution Channel, End User, Route Of Administration - Global Forecast 2025-2030- Product Image

Sale

Respiratory Disease Vaccine Market by Vaccine Type (Conjugate Vaccine, Inactivated Vaccine, Live Attenuated Vaccine), Age Group (Adult, Geriatric, Pediatric), Distribution Channel, End User, Route Of Administration - Global Forecast 2025-2030

Report
194 Pages
August 2025
Region: Global
360iResearch™
ID: 6012369

UP TO €616EUR$697USD£532GBP OFF until Dec 31^st 2025

The respiratory disease vaccine market is evolving rapidly as stakeholders prioritize robust immunization strategies in response to changing virus patterns and recent outbreaks. Strategic collaboration, technological innovation, and adaptive regulatory approaches are shaping an increasingly interconnected industry landscape.

Market Snapshot: Respiratory Disease Vaccine Market Growth

The Respiratory Disease Vaccine Market grew from USD 24.78 billion in 2024 to USD 26.28 billion in 2025. It is expected to continue growing at a CAGR of 5.89%, reaching USD 34.95 billion by 2030. Industry momentum is driven by rising demand for preventative healthcare and new vaccine technologies, as both public and private sector initiatives intensify support for immunization across global populations.

Scope & Segmentation: Comprehensive Market Coverage

This research report delivers granular analyses across multiple dimensions, supporting clear, informed decisions for senior stakeholders:

Vaccine Types: Conjugate vaccines, inactivated vaccines, live attenuated vaccines, mRNA vaccines, subunit vaccines, viral vector vaccines
Age Groups: Adult (including middle-aged, older adult, young adult), geriatric (elderly, senior), pediatric (adolescent, child, infant, toddler)
Distribution Channels: Direct purchase, hospital pharmacy, online pharmacy (mobile app sales, website sales), retail pharmacy (chain pharmacy, independent pharmacy)
End Users: Clinics, home care, hospitals (government, private), research institutes
Route of Administration: Intramuscular, intranasal, oral, subcutaneous
Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and major markets across EMEA), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia)
Leading Companies Analyzed: Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Seqirus Pty Ltd, Moderna, Inc., AstraZeneca plc, Johnson & Johnson, Novavax, Inc., BioNTech SE, Sinovac Biotech Co., Ltd.

Key Takeaways for Senior Decision-Makers

The market landscape is defined by shifting procurement strategies and streamlined alliances that accelerate vaccine delivery and broaden population reach.
Breakthrough technologies, such as mRNA platforms and modular manufacturing systems, are enabling faster adaptation to novel respiratory disease variants and supporting agile supply chains.
Expanded age group targeting—spanning from pediatric to geriatric populations—demonstrates the necessity for tailored formulations and dosing regimens to optimize safety and effectiveness.
Regional policy frameworks vary widely, requiring companies to align market strategies with infrastructure investments and regulatory harmonization across multiple geographies.
Collaborative innovation between established pharmaceutical leaders and emerging biotech firms is critical to the evolution of both vaccine portfolios and competitive positioning.
Distribution models are being transformed through digital platforms, enhanced cold chain management, and improved last-mile reach—addressing both equity and operational excellence.

Tariff Impact: Navigating the U.S. Production Environment

Recent changes to United States tariff policies on vaccine input materials have prompted manufacturers to re-examine sourcing, invest in domestic capacity, and seek targeted tariff exemptions. Companies are increasingly balancing the cost of domestic production with the potential for supply chain interruptions, while public agencies advocate for cost relief on critical vaccine components to support readiness.

Methodology & Data Sources

This study applies mixed-methods research by combining in-depth interviews with vaccine industry executives, supply chain experts, and regulatory authorities, alongside a systematic review of scientific literature, policy documents, and proprietary market databases. Quantitative data is triangulated for validation and accuracy, while qualitative inputs reveal nuanced drivers and barriers throughout regional markets and technology segments.

Why This Report Matters

It provides actionable intelligence for aligning business growth strategies with the most promising technology pathways and market trends in respiratory disease vaccines.
Decision-makers can benchmark company positioning and anticipate market disruptions by leveraging the in-depth segmentation and regional analysis available.
Stakeholders gain a comprehensive perspective on regulatory triggers, partnership opportunities, and operational innovations essential for competitive advantage.

Conclusion

This executive summary presents a clear outlook on the evolving dynamics of the respiratory disease vaccine market. Market participants who adapt technology, regional tactics, and collaborative approaches will be best positioned for future growth and resilience.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

5.1. Integration of mRNA technology to accelerate development of universal RSV vaccines
5.2. Expansion of adjuvant formulations to enhance immunogenicity in elderly populations with influenza vaccines
5.3. Regulatory progression of next-generation intranasal COVID-19 vaccines for mucosal immunity
5.4. Investment in combination vaccines targeting multiple respiratory pathogens to streamline immunization schedules
5.5. Adoption of nanoparticle-based delivery systems to improve stability and efficacy of pediatric RSV vaccines
5.6. Clinical trial advancements in pan-coronavirus vaccines addressing emerging SARS-CoV-2 variants
5.7. Emergence of thermostable vaccine formulations reducing cold chain dependency in global immunization campaigns
5.8. Government funding initiatives supporting universal influenza vaccine research with broad cross-strain protection

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Respiratory Disease Vaccine Market, by Vaccine Type

8.1. Introduction
8.2. Conjugate Vaccine
8.3. Inactivated Vaccine
8.4. Live Attenuated Vaccine
8.5. MRNA Vaccine
8.6. Subunit Vaccine
8.7. Viral Vector Vaccine

9. Respiratory Disease Vaccine Market, by Age Group

9.1. Introduction
9.2. Adult
9.2.1. Middle Aged
9.2.2. Older Adult
9.2.3. Young Adult
9.3. Geriatric
9.3.1. Elderly
9.3.2. Senior
9.4. Pediatric
9.4.1. Adolescent
9.4.2. Child
9.4.3. Infant
9.4.4. Toddler

10. Respiratory Disease Vaccine Market, by Distribution Channel

10.1. Introduction
10.2. Direct Purchase
10.3. Hospital Pharmacy
10.4. Online Pharmacy
10.4.1. Mobile App Sales
10.4.2. Website Sales
10.5. Retail Pharmacy
10.5.1. Chain Pharmacy
10.5.2. Independent Pharmacy

11. Respiratory Disease Vaccine Market, by End User

11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
11.4.1. Government Hospitals
11.4.2. Private Hospitals
11.5. Research Institutes

12. Respiratory Disease Vaccine Market, by Route Of Administration

12.1. Introduction
12.2. Intramuscular
12.3. Intranasal
12.4. Oral
12.5. Subcutaneous

13. Americas Respiratory Disease Vaccine Market

13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina

14. Europe, Middle East & Africa Respiratory Disease Vaccine Market

14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland

15. Asia-Pacific Respiratory Disease Vaccine Market

15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan

16. Competitive Landscape

16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. GlaxoSmithKline plc
16.3.3. Sanofi S.A.
16.3.4. Seqirus Pty Ltd
16.3.5. Moderna, Inc.
16.3.6. AstraZeneca plc
16.3.7. Johnson & Johnson
16.3.8. Novavax, Inc.
16.3.9. BioNTech SE
16.3.10. Sinovac Biotech Co., Ltd.

17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix

List of Figures

FIGURE 1. RESPIRATORY DISEASE VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RESPIRATORY DISEASE VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RESPIRATORY DISEASE VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RESPIRATORY DISEASE VACCINE MARKET: RESEARCHAI
FIGURE 26. RESPIRATORY DISEASE VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 27. RESPIRATORY DISEASE VACCINE MARKET: RESEARCHCONTACTS
FIGURE 28. RESPIRATORY DISEASE VACCINE MARKET: RESEARCHARTICLES

List of Tables

TABLE 1. RESPIRATORY DISEASE VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY MRNA VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY MRNA VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VIRAL VECTOR VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VIRAL VECTOR VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY MIDDLE AGED, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY MIDDLE AGED, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY OLDER ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY OLDER ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY YOUNG ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY YOUNG ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY SENIOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY SENIOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CHILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CHILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TODDLER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TODDLER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DIRECT PURCHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DIRECT PURCHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY MOBILE APP SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY MOBILE APP SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY WEBSITE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY WEBSITE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INTRANASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 152. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 153. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 154. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 155. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 156. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 157. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 158. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 159. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 160. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 161. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 164. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 165. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 166. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 167. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 172. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 173. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 176. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 177. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 178. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 179. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 180. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 181. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 182. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 183. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 286. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 287. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 288. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 289. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 290. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 291. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2018-2024 (USD MILLION)
TABLE 292. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY GERIATRIC, 2025-2030 (USD MILLION)
TABLE 293. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 294. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 295. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 304. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 305. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 308. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 309. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 312. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT, 2025-203

Samples

LOADING...

Companies Mentioned

Pfizer Inc.
GlaxoSmithKline plc
Sanofi S.A.
Seqirus Pty Ltd
Moderna, Inc.
AstraZeneca plc
Johnson & Johnson
Novavax, Inc.
BioNTech SE
Sinovac Biotech Co., Ltd.

Table Information

Report Attribute	Details
No. of Pages	194
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 26.28 Billion
Forecasted Market Value ( USD ) by 2030	$ 34.95 Billion
Compound Annual Growth Rate	5.8%
Regions Covered	Global
No. of Companies Mentioned	10

PURCHASE OPTIONS

Single User License PDF, Excel And Online Access

1 - 5 User License PDF, Excel And Online Access

Site License PDF, Excel And Online Access

Enterprise License PDF, Excel And Online Access

Request Invoice or Quote

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3134EUR$3,545USD£2,706GBP €3483EUR$3,939USD£3,007GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3381EUR$3,824USD£2,919GBP €3757EUR$4,249USD£3,243GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4583EUR$5,183USD£3,956GBP €5092EUR$5,759USD£4,396GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5545EUR$6,272USD£4,788GBP €6162EUR$6,969USD£5,319GBP

Market Snapshot: Respiratory Disease Vaccine Market Growth

Scope & Segmentation: Comprehensive Market Coverage

Key Takeaways for Senior Decision-Makers

Tariff Impact: Navigating the U.S. Production Environment

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Samples

Companies Mentioned

Table Information

Related Topics

Related Reports

Porcine Vaccine: Market Share, and Growth Analysis by Product Type (Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines), Application, End User, Technology

Oral Vaccine Market by Vaccine Type (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Disease Indication (Influenza, Norovirus, Poliovirus), Age Group, Distribution Channel - Global Forecast 2025-2030

Vaccines Market by Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA Vaccines), Product Type (BCG, COVID-19, DPTa), Vaccine Combination, Vaccine Classification, Route of Administration, Dosage, Age Group, End User - Global Forecast 2025-2030

Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By End Use (Private Healthcare Settings), By Region, And Segment Forecasts, 2025 - 2030

Pediatric Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines), By Application (Cancer), By Region, And Segment Forecasts, 2024 - 2030

About the Respiratory Disease Vaccine Market